These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33621778)

  • 21. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
    Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
    J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of the murine SIGNR1 gene encoding a C-type lectin homologous to human DC-SIGN and DC-SIGNR.
    Parent SA; Zhang T; Chrebet G; Clemas JA; Figueroa DJ; Ky B; Blevins RA; Austin CP; Rosen H
    Gene; 2002 Jun; 293(1-2):33-46. PubMed ID: 12137941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides.
    Arnáiz B; Martínez-Ávila O; Falcon-Perez JM; Penadés S
    Bioconjug Chem; 2012 Apr; 23(4):814-25. PubMed ID: 22433013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists.
    Obermajer N; Sattin S; Colombo C; Bruno M; Svajger U; Anderluh M; Bernardi A
    Mol Divers; 2011 May; 15(2):347-60. PubMed ID: 21076980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets.
    Duinkerken S; Horrevorts SK; Kalay H; Ambrosini M; Rutte L; de Gruijl TD; Garcia-Vallejo JJ; van Kooyk Y
    Theranostics; 2019; 9(20):5797-5809. PubMed ID: 31534520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x.
    van Die I; van Vliet SJ; Nyame AK; Cummings RD; Bank CM; Appelmelk B; Geijtenbeek TB; van Kooyk Y
    Glycobiology; 2003 Jun; 13(6):471-8. PubMed ID: 12626400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes.
    Colmenares M; Puig-Kröger A; Pello OM; Corbí AL; Rivas L
    J Biol Chem; 2002 Sep; 277(39):36766-9. PubMed ID: 12122001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals.
    Lozach PY; Burleigh L; Staropoli I; Navarro-Sanchez E; Harriague J; Virelizier JL; Rey FA; Desprès P; Arenzana-Seisdedos F; Amara A
    J Biol Chem; 2005 Jun; 280(25):23698-708. PubMed ID: 15855154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pichia pastoris-produced mucin-type fusion proteins with multivalent O-glycan substitution as targeting molecules for mannose-specific receptors of the immune system.
    Gustafsson A; Sjöblom M; Strindelius L; Johansson T; Fleckenstein T; Chatzissavidou N; Lindberg L; Angström J; Rova U; Holgersson J
    Glycobiology; 2011 Aug; 21(8):1071-86. PubMed ID: 21474492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands.
    Mitchell DA; Fadden AJ; Drickamer K
    J Biol Chem; 2001 Aug; 276(31):28939-45. PubMed ID: 11384997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fasciola hepatica glycoconjugates immuneregulate dendritic cells through the Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin inducing T cell anergy.
    Rodríguez E; Kalay H; Noya V; Brossard N; Giacomini C; van Kooyk Y; García-Vallejo JJ; Freire T
    Sci Rep; 2017 Apr; 7():46748. PubMed ID: 28436457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles.
    Lozach PY; Amara A; Bartosch B; Virelizier JL; Arenzana-Seisdedos F; Cosset FL; Altmeyer R
    J Biol Chem; 2004 Jul; 279(31):32035-45. PubMed ID: 15166245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic analysis of DC-SIGN on dendritic cells detects tetramers required for ligand binding but no association with CD4.
    Bernhard OK; Lai J; Wilkinson J; Sheil MM; Cunningham AL
    J Biol Chem; 2004 Dec; 279(50):51828-35. PubMed ID: 15385553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DC-SIGN antagonists, a potential new class of anti-infectives.
    Anderluh M; Jug G; Svajger U; Obermajer N
    Curr Med Chem; 2012; 19(7):992-1007. PubMed ID: 22257062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
    van Kooyk Y; Unger WW; Fehres CM; Kalay H; García-Vallejo JJ
    Mol Immunol; 2013 Sep; 55(2):143-5. PubMed ID: 23158834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR.
    Feinberg H; Mitchell DA; Drickamer K; Weis WI
    Science; 2001 Dec; 294(5549):2163-6. PubMed ID: 11739956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a novel C-type lectin-like gene, LSECtin: demonstration of carbohydrate binding and expression in sinusoidal endothelial cells of liver and lymph node.
    Liu W; Tang L; Zhang G; Wei H; Cui Y; Guo L; Gou Z; Chen X; Jiang D; Zhu Y; Kang G; He F
    J Biol Chem; 2004 Apr; 279(18):18748-58. PubMed ID: 14711836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High doses of recombinant mannan-binding lectin inhibit the binding of influenza A(H1N1)pdm09 virus with cells expressing DC-SIGN.
    Yu L; Shang S; Tao R; Wang C; Zhang L; Peng H; Chen Y
    APMIS; 2017 Jul; 125(7):655-664. PubMed ID: 28493491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificity of DC-SIGN for mannose- and fucose-containing glycans.
    van Liempt E; Bank CM; Mehta P; Garciá-Vallejo JJ; Kawar ZS; Geyer R; Alvarez RA; Cummings RD; Kooyk Yv; van Die I
    FEBS Lett; 2006 Nov; 580(26):6123-31. PubMed ID: 17055489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AM3 modulates dendritic cell pathogen recognition capabilities by targeting DC-SIGN.
    Serrano-Gómez D; Martínez-Nuñez RT; Sierra-Filardi E; Izquierdo N; Colmenares M; Pla J; Rivas L; Martinez-Picado J; Jimenez-Barbero J; Alonso-Lebrero JL; González S; Corbí AL
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2313-23. PubMed ID: 17452477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.